Xu, H., Han, Y., Lou, J., Zhang, H., Zhao, Y., Győrffy, B., & Li, R. (2017). PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer. Oncotarget.
শিকাগো স্টাইলে সাইটেশনXu, Huiyu, Yong Han, Jiaying Lou, Hongxian Zhang, Yue Zhao, Balázs Győrffy, এবং Rong Li. "PDGFRA, HSD17B4 and HMGB2 Are Potential Therapeutic Targets in Polycystic Ovarian Syndrome and Breast Cancer." Oncotarget 2017.
এমএলএ সাইটেশনXu, Huiyu, et al. "PDGFRA, HSD17B4 and HMGB2 Are Potential Therapeutic Targets in Polycystic Ovarian Syndrome and Breast Cancer." Oncotarget 2017.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.